| Trade Names: | |
| Synonyms: | |
| Status: | Approved (2017) |
| Entry Type: | Antibody |
| Molecule Category: | UNKNOWN |
| ATC: | L01XC26 |
| UNII: | P93RUU11P7 |
Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| BINDING AGENT | CD22 binding agent | PubMed |
| Primary Target | |
|---|---|
| CD22 |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 4 | D054198 | ClinicalTrials |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 4 | D054198 | ClinicalTrials |
| Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 4 | D015452 | FDA |
| Lymphoma, Follicular | 3 | D008224 | ClinicalTrials |
| Lymphoma, Follicular | 3 | D008224 | ClinicalTrials |
| Lymphoma, Non-Hodgkin | 3 | D008228 | ClinicalTrials |
| Lymphoma, Large B-Cell, Diffuse | 2 | D016403 | ClinicalTrials |
| Lymphoma | 2 | D008223 | ClinicalTrials |
| Leukemia, Biphenotypic, Acute | 1 | D015456 | ClinicalTrials |
| Blast Crisis | 1 | D001752 | ClinicalTrials |
| Hematologic Neoplasms | 1 | D019337 | ClinicalTrials |
Adverse Reactions
System Organ Classification (SOC)
Cross References
| Resources | Reference |
|---|---|
| CAS NUMBER | 635715-01-4 |
| ChEMBL | CHEMBL2108611 |
| FDA SRS | P93RUU11P7 |
| Guide to Pharmacology | 8266 |
CONTENTS